Psychological stress is considered as one of the most important factors in the development of motion sickness. The psychological stress impacts intestinal motility, intestinal sensitivity, permeability, and secretion that is co-related with the mucosal immune activation and alterations in the central nervous system.

According to a survey by Buscopan IBS Relief in 2016, stress was the cause for seven out of ten patients suffering from gastrointestinal pain. Thus, increasing number of ... Read more

The global Scopolamine market is estimated to be valued at US$ 462.7 million in 2022 and is expected to exhibit a CAGR of 4.8% over the forecast period, as highlighted in a new report published by Coherent Market Insights.

A) Market Overview:
Scopolamine is a medication used to prevent nausea and vomiting caused by motion sickness or post-operative conditions. It works by blocking certain natural substances in the body that cause nausea and vomiting. The ... Read more

Market Overview:
Scopolamine is an anticholinergic alkaloid which is found in plants of the family Solanaceae, such as Datura stramonium and Atropa belladonna. It is used for preventing nausea, vomiting, and dizziness caused by motion sickness. Scopolamine patches prevents the transmission of nerve impulses responsible for nausea and vomiting, which provides relief to patients suffering from motion sickness.

Market key trends:
One of the key trend in ... Read more

Scopolamine, also known as hyoscine, is an alkaloid drug with widespread medical uses. It acts as a competitive antagonist at muscarinic acetylcholine receptors in the central and peripheral nervous system. Scopolamine is primarily used to treat or prevent motion sickness and postoperative nausea and vomiting. It is available in various formulations such as tablets, patches, injections and creams. Scopolamine patches and tablets are commonly used for preventing motion sickness during travel ... Read more